Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(OP: TYPTF )

0.0250 +0.0020 (+8.70%)
Streaming Delayed Price Updated: 11:54 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about TYPTF

Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials
Tryptamine Therapeutics advances TRP-8803, an IV psilocin therapy with rapid onset and enhanced safety, to Phase 2 clinical trials. 
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.